Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UCSF
Dates
study started
completion around
Principal Investigator
by Mark Pletcher, MD MPH (ucsf)
Headshot of Mark Pletcher
Mark Pletcher

Description

Summary

The BP Activate Study aims to assess the effectiveness of the BP Report letter with personalized BP medication recommendations, compared with Control letters and no intervention, at shortening time to appointment, time to visit, time to medication change, and time to achievement of BP goal.

Official Title

UCSF BP Activate Letter Randomized Clinical Trial

Details

The BP Activate Study is a randomized quality improvement trial. We will deliver one of two versions of a letter to established English-speaking primary care patients at Mt Zion with uncontrolled hypertension, defined by SBP>140 or DBP>90 in the past two years (identified via EHR). The letter will prompt patients to schedule a visit with their provider or team nurse practitioner to discuss their BP recommendations with their clinician. We will test 2 versions of the letter and a usual care control:

  1. The "BP Activate Report Letter" group will get a letter that presents recommendations for medication changes from a computerized algorithm using the patient's medical records and recommends discussing these specific recommendations with their clinician; or
  2. The "Control Letter" group will get a letter that suggests they talk to their clinician about their BP without providing any specific medication recommendations.
  3. The "Usual Care" group will not receive any intervention.

This primary goal of the study is to assess the effectiveness of the BP Activate Report Letter compared with the Control Letter, and see if it shortens time to appointment, time to visit, time to medication change (primary outcome), and time to achievement of BP goal. Clinicians, with patient input, will still have full control of how BP is clinically managed. A small number of patients will be contacted by a research coordinator to hear what they thought when they received the letter, and why they did or did not act upon the information.

Keywords

Hypertension, BP Activate Letter

Eligibility

You can join if…

Open to people ages 18 years and up

  • Patient is a primary care patient of a clinician in a general internal medicine clinic who has agreed to have their patients participate in the study
  • Lowest SBP>140 or lowest DBP>90 at last visit in general internal medicine clinic
  • Last visit in general internal medicine clinic was < 2 years ago
  • EngageRx algorithm determines that a medication intensification step is indicated

You CAN'T join if...

  • Primary language is not English
  • Patient's provider indicates (through an active opt-out process) that they do not want the patient to receive a BP Activate letter

Location

  • University of California, San Francisco
    San Francisco California 94143 United States

Lead Scientist at University of California Health

  • Mark Pletcher, MD MPH (ucsf)
    As an epidemiologist and a general internal medicine physician, my research is designed to inform clinical decision-making and policy relevant to primary care and prevention.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06152094
Study Type
Interventional
Participants
About 484 people participating
Last Updated